Akari Therapeutics, Plc Property, Plant and Equipment
Akari Therapeutics, Plc (AKTX) had Property, Plant and Equipment of $31.81 thousand as of 2024-06-30, per its 8-K filed 2024-09-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2024-09-06
- 2024-06-30: Property, Plant and Equipment, Net $31.81K.
- 2023-12-31: Property, Plant and Equipment, Net $153.11K.
- 2022-12-31: Property, Plant and Equipment, Net $376.65K; Property, Plant and Equipment, Net as first filed $0.00.
- 2021-12-31: Property, Plant and Equipment, Net $0.00.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2024-06-30 | $31.81K 8-K · filed 2024-09-06 | |
| 2023-12-31 | $153.11K 8-K · filed 2024-09-06 | |
| 2022-12-31 | $376.65K 8-K · filed 2024-09-06 | $0.00 20-F · filed 2023-05-01 |
| 2021-12-31 | $0.00 20-F · filed 2023-05-01 | |
| 2020-12-31 | $0.00 20-F · filed 2022-05-16 | |
| 2020-03-31 | $2.10K 20-F · filed 2021-04-21 | |
| 2019-12-31 | $5.01K 20-F · filed 2021-04-21 | |
| 2019-09-30 | $8.39K 20-F · filed 2021-04-21 | |
| 2019-06-30 | $12.06K 20-F · filed 2021-04-21 | |
| 2019-03-31 | $15.83K 20-F · filed 2021-04-21 | |
| 2018-12-31 | $20.43K 20-F · filed 2020-03-31 | |
| 2018-06-30 | $38.70K 6-K · filed 2018-09-27 | |
| 2017-12-31 | $55.90K 20-F · filed 2019-04-23 | |
| 2017-06-30 | $74.20K 6-K · filed 2017-08-10 | |
| 2016-12-31 | $58.36K 20-F · filed 2018-07-18 | |
| 2016-06-30 | $71.24K 6-K · filed 2017-04-14 | |
| 2016-03-31 | $74.76K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $40.51K 6-K · filed 2017-04-14 | |
| 2015-09-30 | $34.93K 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $40.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $44.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-23 | $49.00K 10-K · filed 2015-02-11 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-11 | |
| 2012-12-31 | $2.00K 20-F · filed 2014-03-24 | |
| 2011-12-31 | $0.00 20-F/A · filed 2013-04-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |